Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Corrado Cilio

Professor

Default user image.

Taming killer cells may halt diabetes progression

Author

  • Francesco Colucci
  • Corrado Cilio

Summary, in English

Preclinical studies in mice suggest that the natural killer cell receptor NKp46 may be a new molecular target for delaying the progression of type 1 diabetes by interfering with unexpected natural killer cell-mediated recognition of pancreatic beta cells.

Department/s

  • EXODIAB: Excellence in Diabetes Research in Sweden
  • Diabetes - Immunovirology

Publishing year

2010

Language

English

Pages

111-112

Publication/Series

Nature Immunology

Volume

11

Issue

2

Document type

Journal article (comment)

Publisher

Nature Publishing Group

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Diabetes - Immunovirology

ISBN/ISSN/Other

  • ISSN: 1529-2908